These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34086371)

  • 1. Best practice recommendations for the use of hepatitis C viremic donor organs for hepatitis C virus naïve recipients.
    Stewart ZA; Shah SA; Rolls JA; Guarrera JV; Kandaswamy R; Axelrod DA
    Clin Transplant; 2021 Aug; 35(8):e14381. PubMed ID: 34086371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
    Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
    Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
    Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
    Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of direct acting antiviral therapies in hepatitis C virus-negative liver transplant recipients of hepatitis C-viremic donors.
    Snyder HS; Wiegel JJ; Khalil K; Summers BB; Tan T; Jonchhe S; Kaiser TE
    Pharmacotherapy; 2022 Dec; 42(12):905-920. PubMed ID: 36373198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.
    Lentine KL; Peipert JD; Alhamad T; Caliskan Y; Concepcion BP; Forbes R; Schnitzler M; Chang SH; Cooper M; Bloom RD; Mannon RB; Axelrod DA
    Kidney360; 2020 Nov; 1(11):1291-1299. PubMed ID: 33251523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct-acting antiviral initiation.
    Hudson MR; Webb AR; Logan AT; Silverman A; Brueckner AJ
    Clin Transplant; 2021 Aug; 35(8):e14386. PubMed ID: 34132438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors.
    Smith DE; Chen S; Fargnoli A; Lewis T; Galloway AC; Kon ZN; Moazami N
    Semin Thorac Cardiovasc Surg; 2021; 33(2):407-415. PubMed ID: 32621962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.
    Bethea E; Arvind A; Gustafson J; Andersson K; Pratt D; Bhan I; Thiim M; Corey K; Bloom P; Markmann J; Yeh H; Elias N; Kimura S; Dageforde LA; Cuenca A; Kawai T; Safa K; Williams W; Gilligan H; Sise M; Fishman J; Kotton C; Kim A; Rogers CC; Shao S; Cote M; Irwin L; Myoung P; Chung RT
    Am J Transplant; 2020 Jun; 20(6):1619-1628. PubMed ID: 31887236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors.
    Bova S; Cameron A; Durand C; Katzianer J; LeGrand M; Boyer L; Glorioso J; Toman LP
    Am J Health Syst Pharm; 2022 Jan; 79(3):173-178. PubMed ID: 33987658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report.
    Said A; Weiss M; Varhelyi A; Farago R; Ballweg C; Rice J; Agarwal P; Fernandez L; Foley D
    Transpl Infect Dis; 2021 Apr; 23(2):e13466. PubMed ID: 32931616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
    Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
    Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care.
    Bohorquez H; Bugeaud E; Bzowej N; Scheuermann J; Hand J; Bruce D; Carmody I; Cohen A; Joshi S; Seal J; Sonnier D; Therapondos G; Girgrah N; Anders S; Loss GE
    Liver Transpl; 2021 Apr; 27(4):548-557. PubMed ID: 33098277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
    Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
    Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
    Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
    Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report.
    Cuvelier S; Van Caeseele P; Kadatz M; Peterson K; Sun S; Dodd N; Werestiuk K; Koulack J; Nickerson P; Ho J
    Can J Kidney Health Dis; 2021; 8():20543581211033496. PubMed ID: 34367648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Lung Transplantation From Hepatitis C Viremic Donors.
    Li SS; Osho A; Moonsamy P; Wolfe S; Villavicencio MA; Langer N; Sundt TM; Funamoto M
    Ann Thorac Surg; 2022 May; 113(5):1598-1607. PubMed ID: 34062125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.
    Kapila N; Al-Khalloufi K; Bejarano PA; Vanatta JM; Zervos XB
    Am J Transplant; 2020 Feb; 20(2):600-605. PubMed ID: 31448549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.